Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis
NCT ID: NCT06354010
Last Updated: 2025-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-06-14
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development Cellular Models of the Ear and Nose to Study the Mechanisms of Hearing
NCT04823195
Natural History in Children Up to 16 Years with Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes
NCT05402813
Hearing and Cognition in Aging Adults
NCT06183450
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NCT05312983
A Prospective Cohort Study On Change of Cognitive Function In Aged-related Hearing Loss With Hearing Aids
NCT05694039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who present with adulthood-onset bilateral sensorineural hearing loss will be screened for the presence of mutation involved in hearing impairment. Patients with GJB2 mutations will be proposed to continue in a follow-up period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with adulthood-onset bilateral sensorineural hearing loss (SNHL)
Genotyping
Genotyping to determine if patients present mutations to the gene GJB2.
Patients that carry mutations in the gene GJB2 from patients with adulthood-onset bilateral SNHL
Audiological assessments
Audiological assessments
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Genotyping
Genotyping to determine if patients present mutations to the gene GJB2.
Audiological assessments
Audiological assessments
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Bilateral hearing loss first noticed after the age of 16 years old
3. Documented genotyping results showing mutations in GJB2 gene.
Exclusion Criteria
2. To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures
30 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sensorion
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederic Venail, Pr
Role: PRINCIPAL_INVESTIGATOR
CHU Montpellier - Hôpital Gui de Chauliac
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of South Florida Board of Trustees
Tampa, Florida, United States
CHU Gui de Chauliac
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Victoria Sanchez, MD
Role: primary
Frederic Venail, Pr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SENS-NH02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.